Summaries of lectures on the comprehensive IBMS Biomedical Science Congress scientific lecture programme are requested from individual speakers. In this first of two reviews, Pathology in Practice selects highlights from alphabetically cellular pathology to immunology.
The thirteenth biennial IBMS Congress scientific programme once again illustrates the diverse and evolving nature of specialties that comprise biomedical science and laboratory medicine. Reproduced below are selected summaries from lectures given on the cellular pathology, clinical chemistry, cytopathology, haematology and immunology programmes.
Delivering lung cancer companion diagnostics in the genomics era
Companion diagnostic testing for markers of response to National Institute for Health and Care Excellence (NICE)-approved molecularly targeted therapies is the standard of care for patients diagnosed with locally advanced or metastatic non-small cell lung cancer (NSCLC). These biomarkers comprise somatic variants in kinase genes, including EGFR-activating mutations and gene fusions involving ALK or ROS1, as well as deregulated expression of the immune regulatory protein PD-L1.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
Register
